PROCEEDINGS VOLUME 3247
BIOS '98 INTERNATIONAL BIOMEDICAL OPTICS SYMPOSIUM | 27-29 JANUARY 1998
Optical Methods for Tumor Treatment and Detections: Mechanisms and Techniques in Photodynamic Therapy VII
IN THIS VOLUME

0 Sessions, 19 Papers, 0 Presentations
Clinical  (6)
BIOS '98 INTERNATIONAL BIOMEDICAL OPTICS SYMPOSIUM
27-29 January 1998
San Jose, CA, United States
Clinical
Proc. SPIE 3247, Photodynamic therapy of supratentorial gliomas, 0000 (19 May 1998); doi: 10.1117/12.308129
Proc. SPIE 3247, Photodynamic therapy with Photofrin followed by thermal ablation for elimination of dysplasia and early cancer in Barrett's esophagus: follow-up in 100 patients, 0000 (19 May 1998); doi: 10.1117/12.308135
Proc. SPIE 3247, Photodynamic therapy repeated without reinjection of Photofrin (porfimer sodium), 0000 (19 May 1998); doi: 10.1117/12.308146
Proc. SPIE 3247, Photodynamic therapy trials with lutetium texaphyrin (Lu-Tex) in patients with locally recurrent breast cancer, 0000 (19 May 1998); doi: 10.1117/12.308147
Detection and Imaging
Proc. SPIE 3247, Detection of lutetium texaphyrin (Lutex) using its absorption of tissue autofluorescence, 0000 (19 May 1998); doi: 10.1117/12.308130
Proc. SPIE 3247, Enhancement of lutetium texaphyrin phototherapy with Mitomycin C, 0000 (19 May 1998); doi: 10.1117/12.308131
Proc. SPIE 3247, Confocal observation of hydrophilic and lipophilic photosensitizers in endothelial cells, lumen of the vessels, interstitium, and tumor cells using the chicken chorioallantoic membrane, 0000 (19 May 1998); doi: 10.1117/12.308132
Preclinical and Mechanisms I
Proc. SPIE 3247, Stress-activated signaling responses leading to apoptosis following photodynamic therapy, 0000 (19 May 1998); doi: 10.1117/12.308133
Proc. SPIE 3247, Interleukin-12 reverses the inhibitory impact of photodynamic therapy (PDT) on the murine contact hypersensitivity response, 0000 (19 May 1998); doi: 10.1117/12.308134
Proc. SPIE 3247, Relevance of nitric oxide to the response of tumors to photodynamic therapy, 0000 (19 May 1998); doi: 10.1117/12.308136
Proc. SPIE 3247, Photodynamic-induced inactivation of Propionibacterium acnes, 0000 (19 May 1998); doi: 10.1117/12.308137
Preclinical and Mechanisms II
Proc. SPIE 3247, Role of mitochondrial photodamage in PDT-induced apoptosis, 0000 (19 May 1998); doi: 10.1117/12.308138
Proc. SPIE 3247, Enhancement of 5-aminolevulinic-acid-induced photodynamic therapy using light-dose fractionation and iron-chelating agents, 0000 (19 May 1998); doi: 10.1117/12.308139
Proc. SPIE 3247, Influence of light irradiation on blood oxygen saturation level in vitro and in vivo during photodynamic therapy, 0000 (19 May 1998); doi: 10.1117/12.308140
Poster Session
Proc. SPIE 3247, New balloon catheter system used for PDT in the human urinary bladder: accuracy of light distribution, 0000 (19 May 1998); doi: 10.1117/12.308141
Proc. SPIE 3247, Effect of antioxidants on PDT treatment of cultured tumor cells, 0000 (19 May 1998); doi: 10.1117/12.308142
Clinical
Proc. SPIE 3247, Photodynamic therapy using Photofrin and Foscan and the treatment of malignancies of the head and neck, 0000 (19 May 1998); doi: 10.1117/12.308143
Proc. SPIE 3247, Experimental and clinical results of mTHPC (Foscan)-mediated photodynamic therapy for malignant brain tumors, 0000 (19 May 1998); doi: 10.1117/12.308144
Detection and Imaging
Proc. SPIE 3247, Feasibility studies of electrical impedance spectroscopy for monitoring tissue response to photodynamic therapy, 0000 (19 May 1998); doi: 10.1117/12.308145
Back to Top